BioSpace News Archive

Pharm Country

Global Researchers Mobilize to Improve Quitting Tools as World No Tobacco Day Focuses on Smokers’ Lung Health

New health, science, and technology grants will allow 100+ researchers to explore smoking cessation and harm-reduction innovation

May 29, 2019
·
4 min read
BioForest

CTI BioPharma to Present at the Jefferies Global Healthcare Conference on Wednesday, Jun. 5

CTI BioPharma Corp. announced that management will provide a corporate overview at the Jefferies Global Healthcare Conference at 4:30 p.m. EDT in New York City.

May 29, 2019
·
1 min read
Business

Kadimastem Announces Leadership Changes

Kadimastem, a stem cell-based therapeutic company, announced recently that Yossi Ben Yosef has stepped down as Chief Executive Officer.

May 29, 2019
·
4 min read
Deals

TherapeuticsMD to Host Investor and Analyst Day on June 10, 2019 in New York City

TherapeuticsMD, Inc., an innovative, leading women’s healthcare company, announced that it will host an Investor and Analyst Day on Monday, June 10, 2019, in New York City.

May 29, 2019
·
4 min read
Genetown

AVEO Oncology to Present at the 2019 BIO International Convention

AVEO Oncology announced that Mike Ferraresso, Senior Vice President, Business Analytics and Commercial Operations, will present at the 2019 BIO International Convention in Philadelphia on Wednesday, June 5, 2019 at 4:30 p.m. EDT.

May 29, 2019
·
3 min read
Business

Crescendo Biologics Achieves Another Milestone in its Strategic Collaboration with Takeda

Crescendo’s proprietary transgenic platform and engineering expertise is used to identify and configure Humabody®-based therapeutics against certain targets selected by Takeda.

May 29, 2019
·
2 min read
Deals

Intact Vascular Announces $25 Million Financing with Vensana Capital to Drive Commercialization of the Tack Endovascular System®

Intact Vascular, Inc. announced a $25 million financing with Vensana Capital as the lead investor.

May 29, 2019
·
4 min read
Business

Can-Fite Reports First Quarter 2019 Financial Results & Provides Clinical Update

Can-Fite BioPharma Ltd. announced financial results for the three months ended March 31, 2019.

May 29, 2019
·
10 min read
Drug Development

AgilVax Triggers $2 Million Phase II Fast Track SBIR Grant and Initiates GMP Manufacturing

AgilVax, Inc. announced that the company has triggered Phase II funding of $2 million from its Fast Track Small Business Innovation Research grant awarded by the National Cancer Institute.

May 29, 2019
·
2 min read
Drug Development

Akero Therapeutics Initiates Phase 2a Clinical Trial of Investigational Therapy AKR-001 for the Treatment of NASH

Akero Therapeutics, Inc. announced that it has screened the first patient for its Phase 2a clinical trial evaluating AKR-001, the company’s lead product candidate for the treatment of NASH.

May 29, 2019
·
2 min read